Literature DB >> 20930087

Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study.

Manjula Kurella Tamura1, Dawei Xie, Kristine Yaffe, Debbie L Cohen, Valerie Teal, Scott E Kasner, Steven R Messé, Ashwini R Sehgal, John Kusek, Karen B DeSalvo, Denise Cornish-Zirker, Janet Cohan, Stephen L Seliger, Glenn M Chertow, Alan S Go.   

Abstract

BACKGROUND AND OBJECTIVES: Cognitive impairment is common among persons with chronic kidney disease, but the extent to which nontraditional vascular risk factors mediate this association is unclear. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted cross-sectional analyses of baseline data collected from adults with chronic kidney disease participating in the Chronic Renal Insufficiency Cohort study. Cognitive impairment was defined as a Modified Mini-Mental State Exam score>1 SD below the mean score.
RESULTS: Among 3591 participants, the mean age was 58.2±11.0 years, and the mean estimated GFR (eGFR) was 43.4±13.5 ml/min per 1.73 m2. Cognitive impairment was present in 13%. After adjustment for demographic characteristics, prevalent vascular disease (stroke, coronary artery disease, and peripheral arterial disease) and traditional vascular risk factors (diabetes, hypertension, smoking, and elevated cholesterol), an eGFR<30 ml/min per 1.73 m2 was associated with a 47% increased odds of cognitive impairment (odds ratio 1.47, 95% confidence interval 1.05, 2.05) relative to those with an eGFR 45 to 59 ml/min per 1.73 m2. This association was attenuated and no longer significant after adjustment for hemoglobin concentration. While other nontraditional vascular risk factors including C-reactive protein, homocysteine, serum albumin, and albuminuria were correlated with cognitive impairment in unadjusted analyses, they were not significantly associated with cognitive impairment after adjustment for eGFR and other confounders.
CONCLUSIONS: The prevalence of cognitive impairment was higher among those with lower eGFR, independent of traditional vascular risk factors. This association may be explained in part by anemia.

Entities:  

Mesh:

Year:  2010        PMID: 20930087      PMCID: PMC3052213          DOI: 10.2215/CJN.02660310

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  36 in total

1.  Microalbuminuria, peripheral artery disease, and cognitive function.

Authors:  S Vupputuri; D A Shoham; S L Hogan; A V Kshirsagar
Journal:  Kidney Int       Date:  2007-11-21       Impact factor: 10.612

2.  Kidney function and cognitive performance and decline in older men.

Authors:  Yelena Slinin; Misti L Paudel; Areef Ishani; Brent C Taylor; Kristine Yaffe; Anne M Murray; Howard A Fink; Eric S Orwoll; Steven R Cummings; Elizabeth Barrett-Connor; Simerjot Jassal; Kristine E Ensrud
Journal:  J Am Geriatr Soc       Date:  2008-09-15       Impact factor: 5.562

Review 3.  Anemia and cerebral outcomes: many questions, fewer answers.

Authors:  Gregory M T Hare; Albert K Y Tsui; Anya T McLaren; Tenille E Ragoonanan; Julie Yu; C David Mazer
Journal:  Anesth Analg       Date:  2008-10       Impact factor: 5.108

4.  Albuminuria, cognitive functioning, and white matter hyperintensities in homebound elders.

Authors:  Daniel E Weiner; Keith Bartolomei; Tammy Scott; Lori Lyn Price; John L Griffith; Irwin Rosenberg; Andrew S Levey; Marshal F Folstein; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2008-12-12       Impact factor: 8.860

5.  A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Authors:  Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto
Journal:  N Engl J Med       Date:  2009-10-30       Impact factor: 91.245

Review 6.  Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Manjula Kurella Tamura; Virginia Wadley; Kristine Yaffe; Leslie A McClure; George Howard; Rodney Go; Richard M Allman; David G Warnock; William McClellan
Journal:  Am J Kidney Dis       Date:  2008-06-30       Impact factor: 8.860

7.  Albuminuria and dementia in the elderly: a community study.

Authors:  Joshua I Barzilay; Annette L Fitzpatrick; Jose Luchsinger; Sevil Yasar; Charles Bernick; Nancy S Jenny; Lewis H Kuller
Journal:  Am J Kidney Dis       Date:  2008-05-12       Impact factor: 8.860

8.  Risk factors for dementia in the cardiovascular health cognition study.

Authors:  Lewis H Kuller; Oscar L Lopez; Anne Newman; Norman J Beauchamp; Greg Burke; Corinne Dulberg; Annette Fitzpatrick; Linda Fried; Mary N Haan
Journal:  Neuroepidemiology       Date:  2003 Jan-Feb       Impact factor: 3.282

9.  Kidney function is related to cerebral small vessel disease.

Authors:  M Arfan Ikram; Meike W Vernooij; Albert Hofman; Wiro J Niessen; Aad van der Lugt; Monique M B Breteler
Journal:  Stroke       Date:  2007-11-29       Impact factor: 7.914

10.  Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial.

Authors:  Tali Cukierman-Yaffe; Hertzel C Gerstein; Jeff D Williamson; Ronald M Lazar; Laura Lovato; Michael E Miller; Laura H Coker; Anne Murray; Mark D Sullivan; Santica M Marcovina; Lenore J Launer
Journal:  Diabetes Care       Date:  2009-02       Impact factor: 17.152

View more
  62 in total

1.  Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States.

Authors:  Manjula Kurella Tamura; Paul Muntner; Virginia Wadley; Mary Cushman; Neil A Zakai; Brian D Bradbury; Brett Kissela; Fred Unverzagt; George Howard; David Warnock; William McClellan
Journal:  Am J Kidney Dis       Date:  2011-08-04       Impact factor: 8.860

2.  Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: a prospective study.

Authors:  Arpita Basu; Alicia J Jenkins; Julie A Stoner; Suzanne R Thorpe; Richard L Klein; Maria F Lopes-Virella; W Timothy Garvey; Timothy J Lyons
Journal:  Atherosclerosis       Date:  2014-07-15       Impact factor: 5.162

Review 3.  Cognitive impairment in chronic kidney disease: clinical findings, risk factors and consequences for patient care.

Authors:  Dirk M Hermann; Andreas Kribben; Heike Bruck
Journal:  J Neural Transm (Vienna)       Date:  2014-01-23       Impact factor: 3.575

4.  Evaluation of Screening Tests for Cognitive Impairment in Patients Receiving Maintenance Hemodialysis.

Authors:  David A Drew; Hocine Tighiouart; Jasmine Rollins; Sarah Duncan; Seda Babroudi; Tammy Scott; Daniel E Weiner; Mark J Sarnak
Journal:  J Am Soc Nephrol       Date:  2020-03-04       Impact factor: 10.121

5.  Predictors and Outcomes of Health-Related Quality of Life in Adults with CKD.

Authors:  Anna C Porter; James P Lash; Dawei Xie; Qiang Pan; Jennifer DeLuca; Radhika Kanthety; John W Kusek; Claudia M Lora; Lisa Nessel; Ana C Ricardo; Julie Wright Nunes; Michael J Fischer
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-31       Impact factor: 8.237

Review 6.  Cognitive and physical function in chronic kidney disease.

Authors:  Daniel E Weiner; Stephen L Seliger
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-05       Impact factor: 2.894

7.  The association of discharge decisions after deceased donor kidney transplantation with the risk of early readmission: Results from the deceased donor study.

Authors:  Meera Nair Harhay; Yaqi Jia; Heather Thiessen-Philbrook; Behdad Besharatian; Ramnika Gumber; Francis L Weng; Isaac E Hall; Mona Doshi; Bernd Schroppel; Chirag R Parikh; Peter P Reese
Journal:  Clin Transplant       Date:  2018-03-03       Impact factor: 2.863

Review 8.  Cognitive Impairment in CKD: Pathophysiology, Management, and Prevention.

Authors:  David A Drew; Daniel E Weiner; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2019-08-01       Impact factor: 8.860

Review 9.  Kidney-brain crosstalk in the acute and chronic setting.

Authors:  Renhua Lu; Matthew C Kiernan; Anne Murray; Mitchell H Rosner; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2015-08-18       Impact factor: 28.314

10.  Frailty and Cognitive Function in Incident Hemodialysis Patients.

Authors:  Mara A McAdams-DeMarco; Jingwen Tan; Megan L Salter; Alden Gross; Lucy A Meoni; Bernard G Jaar; Wen-Hong Linda Kao; Rulan S Parekh; Dorry L Segev; Stephen M Sozio
Journal:  Clin J Am Soc Nephrol       Date:  2015-11-16       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.